The market moves on news. See it first.
SEC filings, analyst ratings, insider trades, FDA decisions and press releases in one real-time feed, with alerts on the tickers you follow.
- PRValneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026VALN
- PRThe TJX Companies, Inc. to Report Q3 FY27 Results November 18, 2026TJX
- PRSkyFi's 'Satellite Intelligence' Now Available as a Robinhood Agent AppHOOD · BKSY
- PRSPECTRUM BUSINESS LAUNCHES A NEW SECURE NETWORKING OFFERINGCHTR
- PRMasterCraft Boat Holdings, Inc., Expands Dealer Network Across its Portfolio During Q1 2026 Transition PeriodMCFT
- PRMoleculin Announces Acceptance of Annamycin Data for Presentation at the 2026 American Society of Hematology (ASH) Annual MeetingMBRX
Wired into the primary sources
- SEC EDGAR
- FDA
- Business Wire
- PR Newswire
- GlobeNewswire
- Accesswire
- Newsfile
- Cision
Every listed US company. Mega caps to micro caps.
Everything that moves a stock. Nothing that doesn't.
Stop refreshing EDGAR, five newswires and a ratings site. Quantisnow analyzes every source as it publishes, scans it for material info and tags each item to the companies it mentions.
Filings the minute they land
8-Ks, 13Ds, S-1s and Form 4s, analyzed and tagged to the ticker.
Alerts on what you follow
Email or push the moment something new hits a ticker you follow.
Analyst moves
Upgrades, downgrades and price-target changes as they publish.
Insiders putting money in
Executive buys and sells from Form 4, in plain English.
Built for speed
Keyboard first, audio squawk, and a feed that never makes you refresh.
From the wire to your screen in 350ms.
- 01
Follow your tickers
Pick the companies you hold or watch. Sectors and industries work too.
- 02
We analyze every source
Filings, newswires, ratings and FDA notices are read the moment they publish and tagged to each company.
- 03
You hear it first
The item lands in your feed and, on Plus, in your inbox or phone before most investors have seen it.
- Wire to Quantisnow
- 13ms
- Analyzed for material info
- 150ms
- Alerts sent
- 350ms
- Free plan delay
- 3 min
Anatomy of a press release
From the newswire to your phone in 350ms. Free readers wait 3 minutes.
T+0
Newswire publishes
Business Wire, PR Newswire, EDGAR
+13ms
Quantisnow has it
Straight off the wire
+150ms
Analyzed
Scanned for material info, tagged to tickers
+350ms
Alerts sent
Plus feed, push and email
+3 min
Free feed shows it
3 min delay
- T+0Newswire publishesBusiness Wire, PR Newswire, EDGAR
- +13msQuantisnow has itStraight off the wire
- +150msAnalyzedScanned for material info, tagged to tickers
- +350msAlerts sentPlus feed, push and email
- +3 minFree feed shows it3 min delay
The wire, in your pocket.
Follow a ticker and every filing, rating and FDA decision on it is pushed to your phone 350ms after the source publishes. No refreshing, no tabs left open.
- Push alerts per ticker, you pick which kinds
- The live feed, filters and your follows, synced with the web
- One account on your phone and your desk
Today on the wire
A delayed sample of the live feed. Plus members see each item the instant it lands.
Start free. Upgrade when you're ready.
Free
- Every feed on a 3-minute delay
- Follow a small set of tickers
- Daily email digest
- Company pages, ratings and filing history
Plus
Real-time- Real-time feed, no delay
- Follow up to 250 tickers
- Instant email and push alerts
- Audio beep and squawk
- Full news archive
Billed monthly through Stripe. Cancel in one click. Full pricing and FAQ
Referral program
Know a trader? Get 15% of what they pay back, for life.
Share your link. Traders who subscribe through it get 15% off for good, and 15% of every invoice they pay comes back to you as account credit. No cap. Free accounts can refer too.
Get in front of retail investors.
Publish your research or press release, fix a newsitem, or place a sponsored link on an existing article. Flat fees, paid through Stripe, no subscription.
$150
Publish an article
Editor-reviewed, then live on Quantisnow and sent to everyone following the tickers you tag.
From $99
Sponsored link
A link to your site inside an existing article. Charged only if approved.
$100
Amend a newsitem
Correct the headline, summary, body, or tickers of anything on the wire.
Research
After the Headline: News, Bursts and Momentum in US Stocks
A whitepaper on what follows the news, from 144,659 news items and 1.2 million stock-sessions, with open data and code.
Questions, answered.
01Where does the news come from?
Directly from the primary sources: SEC EDGAR, the FDA, and the major newswires including Business Wire, PR Newswire, GlobeNewswire and Accesswire, plus analyst rating changes.
02What's the difference between Free and Plus?
Free shows every feed and sends email alerts on a 3-minute delay, on up to 5 tickers. Plus removes the delay and the limits and adds push, with alerts that go out about 350ms after the source publishes, audio squawk and the full archive.
03Can I cancel anytime?
Yes. Cancel in one click from Settings, Billing. You keep Plus through the end of the month or year you paid for. Payments are never refunded.
04Is there a referral program?
Yes. Every account, free or paid, gets a referral link in Settings. Traders who subscribe through it get 15% off for good, and you get credit worth 15% of every invoice they pay, for life. Credit has no cash value. Details on /referral.
05Is there an API, webhooks or a team plan?
Webhooks come with Premium at $420 a month: every matching item is POSTed as JSON to your own endpoints, Slack or Discord. Team plans and programmatic access run on a separate agreement. Email contact@quantisnow.com with your use case.
Most read today
View all- SEC Form 144 filed by Fermi Inc.
- Chief Financial Officer Khan Salman Hassan covered exercise/tax liability with 33,569 shares, decreasing direct ownership by 2% to 1,320,655 units (SEC Form 4)
- Chief Financial Officer Ling Hai exercised 8,635 shares at a strike of $112.31 and sold $5,541,210 worth of shares (8,635 units at $641.72) as part of a pre-agreed trading plan (SEC Form 4)
- 3M Reaches Broad Resolution of AFFF Personal Injury Litigation
- FDA Approval for BENLYSTA issued to GLAXOSMITHKLINE LLC
- Redwood Trust Plans C-Corporation Conversion and Preferred-for-Common Stock Exchange Offer at a Premium